$VRAY Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ViewRay, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in ViewRay, Inc.. Get notifications about new insider transactions in ViewRay, Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 10 2021 | VRAY | ViewRay, Inc. | Strong Influence Ltd | 10% Owner | Sell | S | 5.97 | 4,300,000 | 25,671,000 | 15,108,222 | 19.4 M to 15.1 M (-22.16 %) |
May 20 2021 | VRAY | ViewRay, Inc. | Castelein Caley | Director | Option Exercise | P | 3.17 | 28,706 | 90,998 | 39,798 | |
May 20 2021 | VRAY | ViewRay, Inc. | Castelein Caley | Director | Option Exercise | P | 2.95 | 74,117 | 218,645 | 102,753 | |
Feb 11 2021 | VRAY | ViewRay, Inc. | Spencer Phillip M | Director | Grant | A | 4.91 | 9,708 | 47,666 | 13,708 | 4 K to 13.7 K (+242.70 %) |
Jan 05 2021 | VRAY | ViewRay, Inc. | Xie Yili Kevin | Director | Grant | A | 3.82 | 2,456 | 9,382 | 149,323 | 146.9 K to 149.3 K (+1.67 %) |
Jan 05 2021 | VRAY | ViewRay, Inc. | WILENSKY GAIL R | Director | Grant | A | 6.41 | 7,800 | 49,998 | 113,791 | 106 K to 113.8 K (+7.36 %) |
Jan 05 2021 | VRAY | ViewRay, Inc. | WILENSKY GAIL R | Director | Grant | A | 3.82 | 3,072 | 11,735 | 105,991 | 102.9 K to 106 K (+2.98 %) |
Jan 05 2021 | VRAY | ViewRay, Inc. | GROSSMAN D KEITH | Director | Grant | A | 6.41 | 7,800 | 49,998 | 100,855 | 93.1 K to 100.9 K (+8.38 %) |
Jan 05 2021 | VRAY | ViewRay, Inc. | Castelein Caley | Director | Grant | A | 6.41 | 8,580 | 54,998 | 795,095 | 786.5 K to 795.1 K (+1.09 %) |
Jan 05 2021 | VRAY | ViewRay, Inc. | Castelein Caley | Director | Grant | A | 3.82 | 2,521 | 9,630 | 786,515 | 784 K to 786.5 K (+0.32 %) |
Jan 05 2021 | VRAY | ViewRay, Inc. | Moore Daniel Jeffrey | Director | Grant | A | 6.41 | 14,820 | 94,996 | 136,984 | 122.2 K to 137 K (+12.13 %) |
Jan 05 2021 | VRAY | ViewRay, Inc. | Moore Daniel Jeffrey | Director | Grant | A | 3.82 | 5,184 | 19,803 | 122,164 | 117 K to 122.2 K (+4.43 %) |
Jan 04 2021 | VRAY | ViewRay, Inc. | Drake Scott William | President & CEO | Payment of Exercise | F | 3.82 | 139,289 | 532,084 | 3,523,021 | 3.7 M to 3.5 M (-3.80 %) |
Jan 04 2021 | VRAY | ViewRay, Inc. | Drake Scott William | President & CEO | Payment of Exercise | F | 3.82 | 139,289 | 532,084 | 3,523,021 | 3.7 M to 3.5 M (-3.80 %) |
Nov 12 2020 | VRAY | ViewRay, Inc. | Drake Scott William | President & CEO | Buy | P | 3.23 | 155,000 | 499,906 | 3,662,310 | 3.5 M to 3.7 M (+4.42 %) |
Oct 27 2020 | VRAY | ViewRay, Inc. | Dempsey James F. | Chief Scientific Of ... | Payment of Exercise | F | 3.05 | 38,012 | 115,937 | 637,138 | 675.2 K to 637.1 K (-5.63 %) |
Oct 27 2020 | VRAY | ViewRay, Inc. | Matin Shahriar | Chief Operating Off ... | Payment of Exercise | F | 3.05 | 91,626 | 279,459 | 1,688,482 | 1.8 M to 1.7 M (-5.15 %) |
Oct 27 2020 | VRAY | ViewRay, Inc. | Drake Scott William | President & CEO | Payment of Exercise | F | 3.05 | 74,167 | 226,209 | 3,507,310 | 3.6 M to 3.5 M (-2.07 %) |
Jul 24 2020 | VRAY | ViewRay, Inc. | Drake Scott William | President & CEO | Payment of Exercise | F | 2.45 | 169,323 | 414,841 | 3,581,477 | 3.8 M to 3.6 M (-4.51 %) |
Jul 24 2020 | VRAY | ViewRay, Inc. | Matin Shahriar | Chief Operating Off ... | Payment of Exercise | F | 2.45 | 84,662 | 207,422 | 1,780,108 | 1.9 M to 1.8 M (-4.54 %) |
Jun 17 2020 | VRAY | ViewRay, Inc. | Xie Yili Kevin | Director | Grant | A | 0.00 | 52,752 | 0 | 146,867 | 94.1 K to 146.9 K (+56.05 %) |
Jun 17 2020 | VRAY | ViewRay, Inc. | WILENSKY GAIL R | Director | Grant | A | 0.00 | 52,752 | 0 | 102,919 | 50.2 K to 102.9 K (+105.15 %) |
Jun 17 2020 | VRAY | ViewRay, Inc. | ROBERTS BRIAN K | Director | Grant | A | 0.00 | 52,752 | 0 | 112,002 | 59.3 K to 112 K (+89.03 %) |
Jun 17 2020 | VRAY | ViewRay, Inc. | JOHNSON B KRISTINE | Director | Grant | A | 0.00 | 52,752 | 0 | 151,968 | 99.2 K to 152 K (+53.17 %) |
Jun 17 2020 | VRAY | ViewRay, Inc. | Huennekens R Scott | Director | Grant | A | 0.00 | 52,752 | 0 | 99,670 | 46.9 K to 99.7 K (+112.43 %) |
Jun 17 2020 | VRAY | ViewRay, Inc. | GROSSMAN D KEITH | Director | Grant | A | 0.00 | 52,752 | 0 | 93,055 | 40.3 K to 93.1 K (+130.89 %) |
Jun 17 2020 | VRAY | ViewRay, Inc. | Castelein Caley | Director | Grant | A | 0.00 | 52,752 | 0 | 783,994 | 731.2 K to 784 K (+7.21 %) |
Jun 17 2020 | VRAY | ViewRay, Inc. | Moore Daniel Jeffrey | Director | Grant | A | 0.00 | 52,752 | 0 | 116,980 | 64.2 K to 117 K (+82.13 %) |
Jun 17 2020 | VRAY | ViewRay, Inc. | Drake Scott William | President & CEO | Grant | A | 0.00 | 914,304 | 0 | 3,750,800 | 2.8 M to 3.8 M (+32.23 %) |
Jun 03 2020 | VRAY | ViewRay, Inc. | Stassen Zachary William | Chief Financial Off ... | Option Exercise | A | 1.81 | 495,079 | 896,093 | 495,079 | |
Jun 03 2020 | VRAY | ViewRay, Inc. | Stassen Zachary William | Chief Financial Off ... | Grant | A | 0.00 | 345,303 | 0 | 345,303 | 0 to 345.3 K |
May 05 2020 | VRAY | ViewRay, Inc. | JOHNSON B KRISTINE | Director | Grant | A | 0.00 | 92,105 | 0 | 99,216 | 7.1 K to 99.2 K (+1,295.25 %) |
May 05 2020 | VRAY | ViewRay, Inc. | JOHNSON B KRISTINE | Director | Grant | A | 0.00 | 7,111 | 0 | 7,111 | 0 to 7.1 K |
Jan 06 2020 | VRAY | ViewRay, Inc. | GROSSMAN D KEITH | Director | Grant | A | 0.00 | 12,707 | 0 | 40,303 | 27.6 K to 40.3 K (+46.05 %) |
Jan 06 2020 | VRAY | ViewRay, Inc. | Huennekens R Scott | Director | Grant | A | 0.00 | 12,707 | 0 | 46,918 | 34.2 K to 46.9 K (+37.14 %) |
Jan 06 2020 | VRAY | ViewRay, Inc. | ROBERTS BRIAN K | Director | Grant | A | 0.00 | 12,707 | 0 | 59,250 | 46.5 K to 59.3 K (+27.30 %) |
Jan 06 2020 | VRAY | ViewRay, Inc. | Castelein Caley | Director | Grant | A | 0.00 | 12,707 | 0 | 734,626 | 721.9 K to 734.6 K (+1.76 %) |
Jan 06 2020 | VRAY | ViewRay, Inc. | Castelein Caley | Director | Grant | A | 4.06 | 15,289 | 61,997 | 721,919 | 706.6 K to 721.9 K (+2.16 %) |
Jan 06 2020 | VRAY | ViewRay, Inc. | Xie Yili Kevin | Director | Grant | A | 0.00 | 12,707 | 0 | 96,571 | 83.9 K to 96.6 K (+15.15 %) |
Jan 06 2020 | VRAY | ViewRay, Inc. | Xie Yili Kevin | Director | Grant | A | 4.06 | 11,097 | 44,998 | 83,864 | 72.8 K to 83.9 K (+15.25 %) |
Jan 06 2020 | VRAY | ViewRay, Inc. | WILENSKY GAIL R | Director | Grant | A | 0.00 | 12,707 | 0 | 52,623 | 39.9 K to 52.6 K (+31.83 %) |
Jan 06 2020 | VRAY | ViewRay, Inc. | WILENSKY GAIL R | Director | Grant | A | 4.06 | 11,097 | 44,998 | 39,916 | 28.8 K to 39.9 K (+38.51 %) |
Jan 06 2020 | VRAY | ViewRay, Inc. | Moore Daniel Jeffrey | Director | Grant | A | 0.00 | 12,707 | 0 | 69,412 | 56.7 K to 69.4 K (+22.41 %) |
Jan 06 2020 | VRAY | ViewRay, Inc. | Moore Daniel Jeffrey | Director | Grant | A | 4.06 | 23,427 | 94,996 | 56,705 | 33.3 K to 56.7 K (+70.40 %) |
Jan 06 2020 | VRAY | ViewRay, Inc. | Drake Scott William | President & CEO | Grant | A | 0.00 | 744,091 | 0 | 2,606,983 | 1.9 M to 2.6 M (+39.94 %) |
Dec 10 2019 | VRAY | ViewRay, Inc. | Strong Influence Ltd | 10% Owner | Buy | P | 3.13 | 5,750,798 | 17,999,998 | 19,408,222 | 13.7 M to 19.4 M (+42.11 %) |
Dec 10 2019 | VRAY | ViewRay, Inc. | Fosun International Ltd | 10% Owner | Buy | P | 3.13 | 1,597,444 | 5,000,000 | 1,597,444 | 0 to 1.6 M |
Dec 10 2019 | VRAY | ViewRay, Inc. | Fosun International Ltd | 10% Owner | Buy | P | 3.13 | 5,750,798 | 17,999,998 | 19,408,222 | 13.7 M to 19.4 M (+42.11 %) |
Dec 10 2019 | VRAY | ViewRay, Inc. | Strong Influence Ltd | 10% Owner | Buy | P | 3.13 | 5,750,798 | 17,999,998 | 19,408,222 | 13.7 M to 19.4 M (+42.11 %) |
Dec 10 2019 | VRAY | ViewRay, Inc. | Fosun International Ltd | 10% Owner | Buy | P | 3.13 | 1,597,444 | 5,000,000 | 1,597,444 | 0 to 1.6 M |
Dec 10 2019 | VRAY | ViewRay, Inc. | Fosun International Ltd | 10% Owner | Buy | P | 3.13 | 5,750,798 | 17,999,998 | 19,408,222 | 13.7 M to 19.4 M (+42.11 %) |
Nov 07 2019 | VRAY | ViewRay, Inc. | Xie Yili Kevin | Director | Grant | A | 0.00 | 10,267 | 0 | 72,767 | 62.5 K to 72.8 K (+16.43 %) |
Nov 07 2019 | VRAY | ViewRay, Inc. | Xie Yili Kevin | Director | Grant | A | 0.00 | 62,500 | 0 | 62,500 | 0 to 62.5 K |
Oct 28 2019 | VRAY | ViewRay, Inc. | Knaley Brian | Sr VP and Interim C ... | Grant | A | 0.00 | 100,000 | 0 | 101,075 | 1.1 K to 101.1 K (+9,302.33 %) |
Oct 28 2019 | VRAY | ViewRay, Inc. | Dempsey James F. | Chief Scientific Of ... | Grant | A | 0.00 | 230,000 | 0 | 450,973 | 221 K to 451 K (+104.09 %) |
Oct 28 2019 | VRAY | ViewRay, Inc. | Alecxih James | Chief Commercial Of ... | Grant | A | 0.00 | 240,000 | 0 | 278,371 | 38.4 K to 278.4 K (+625.47 %) |
Oct 28 2019 | VRAY | ViewRay, Inc. | Matin Shahriar | Chief Operating Off ... | Grant | A | 0.00 | 625,000 | 0 | 1,292,862 | 667.9 K to 1.3 M (+93.58 %) |
Oct 28 2019 | VRAY | ViewRay, Inc. | Drake Scott William | President & CEO | Grant | A | 0.00 | 1,250,000 | 0 | 2,606,983 | 1.4 M to 2.6 M (+92.12 %) |
Sep 04 2019 | VRAY | ViewRay, Inc. | Dempsey James F. | Chief Scientific Of ... | Option Exercise | M | 0.70 | 63,257 | 44,280 | 0 | |
Sep 04 2019 | VRAY | ViewRay, Inc. | Dempsey James F. | Chief Scientific Of ... | Option Exercise | M | 0.68 | 164,697 | 111,994 | 0 | |
Sep 04 2019 | VRAY | ViewRay, Inc. | Dempsey James F. | Chief Scientific Of ... | Option Exercise | M | 0.68 | 51,460 | 34,993 | 0 | |
Sep 04 2019 | VRAY | ViewRay, Inc. | Dempsey James F. | Chief Scientific Of ... | Sell | S | 3.57 | 63,257 | 225,574 | 220,973 | 284.2 K to 221 K (-22.26 %) |
Sep 04 2019 | VRAY | ViewRay, Inc. | Dempsey James F. | Chief Scientific Of ... | Buy | M | 0.70 | 63,257 | 44,280 | 284,230 | 221 K to 284.2 K (+28.63 %) |
Sep 04 2019 | VRAY | ViewRay, Inc. | Dempsey James F. | Chief Scientific Of ... | Sell | S | 3.57 | 164,697 | 587,310 | 220,973 | 385.7 K to 221 K (-42.70 %) |
Sep 04 2019 | VRAY | ViewRay, Inc. | Dempsey James F. | Chief Scientific Of ... | Buy | M | 0.68 | 164,697 | 111,994 | 385,670 | 221 K to 385.7 K (+74.53 %) |
Sep 04 2019 | VRAY | ViewRay, Inc. | Dempsey James F. | Chief Scientific Of ... | Sell | S | 3.57 | 51,460 | 183,506 | 220,973 | 272.4 K to 221 K (-18.89 %) |
Sep 04 2019 | VRAY | ViewRay, Inc. | Dempsey James F. | Chief Scientific Of ... | Buy | M | 0.68 | 51,460 | 34,993 | 272,433 | 221 K to 272.4 K (+23.29 %) |
Aug 15 2019 | VRAY | ViewRay, Inc. | Matin Shahriar | Chief Operating Off ... | Buy | P | 4.02 | 60,000 | 241,200 | 667,862 | 607.9 K to 667.9 K (+9.87 %) |
Aug 13 2019 | VRAY | ViewRay, Inc. | Drake Scott William | President & CEO | Buy | P | 3.81 | 131,260 | 500,048 | 1,356,983 | 1.2 M to 1.4 M (+10.71 %) |
Aug 07 2019 | VRAY | ViewRay, Inc. | Matin Shahriar | Chief Operating Off ... | Payment of Exercise | F | 9.49 | 84,662 | 803,442 | 607,862 | 692.5 K to 607.9 K (-12.23 %) |
Aug 07 2019 | VRAY | ViewRay, Inc. | Drake Scott William | President & CEO | Payment of Exercise | F | 9.49 | 169,324 | 1,606,885 | 1,225,723 | 1.4 M to 1.2 M (-12.14 %) |
Aug 05 2019 | VRAY | ViewRay, Inc. | WILENSKY GAIL R | Director | Option Exercise | A | 8.82 | 19,841 | 174,998 | 19,841 | |
Aug 05 2019 | VRAY | ViewRay, Inc. | WILENSKY GAIL R | Director | Grant | A | 8.82 | 6,519 | 57,498 | 8,978 | 2.5 K to 9 K (+265.11 %) |
Aug 05 2019 | VRAY | ViewRay, Inc. | WILENSKY GAIL R | Director | Grant | A | 9.19 | 2,459 | 22,598 | 2,459 | 0 to 2.5 K |
Aug 02 2019 | VRAY | ViewRay, Inc. | Dempsey James F. | Chief Scientific Of ... | Option Exercise | M | 0.68 | 16,469 | 11,199 | 164,697 | |
Aug 02 2019 | VRAY | ViewRay, Inc. | Dempsey James F. | Chief Scientific Of ... | Option Exercise | M | 0.68 | 5,146 | 3,499 | 51,457 | |
Aug 02 2019 | VRAY | ViewRay, Inc. | Dempsey James F. | Chief Scientific Of ... | Sell | S | 8.97 | 16,469 | 147,791 | 220,973 | 237.4 K to 221 K (-6.94 %) |
Aug 02 2019 | VRAY | ViewRay, Inc. | Dempsey James F. | Chief Scientific Of ... | Buy | M | 0.68 | 16,469 | 11,199 | 237,442 | 221 K to 237.4 K (+7.45 %) |
Aug 02 2019 | VRAY | ViewRay, Inc. | Dempsey James F. | Chief Scientific Of ... | Sell | S | 8.98 | 5,146 | 46,188 | 220,973 | 226.1 K to 221 K (-2.28 %) |
Aug 02 2019 | VRAY | ViewRay, Inc. | Dempsey James F. | Chief Scientific Of ... | Buy | M | 0.68 | 5,146 | 3,499 | 226,119 | 221 K to 226.1 K (+2.33 %) |
Jul 29 2019 | VRAY | ViewRay, Inc. | BANSAL AJAY | Chief Financial Off ... | Option Exercise | X | 3.17 | 12,519 | 39,685 | 0 | |
Jul 29 2019 | VRAY | ViewRay, Inc. | BANSAL AJAY | Chief Financial Off ... | Payment of Exercise | F | 9.00 | 4,408 | 39,672 | 98,876 | 103.3 K to 98.9 K (-4.27 %) |
Jul 29 2019 | VRAY | ViewRay, Inc. | BANSAL AJAY | Chief Financial Off ... | Buy | X | 3.17 | 12,519 | 39,685 | 103,284 | 90.8 K to 103.3 K (+13.79 %) |
Mar 05 2019 | VRAY | ViewRay, Inc. | Matin Shahriar | Chief Operating Off ... | Option Exercise | A | 8.47 | 157,022 | 1,329,976 | 157,022 | |
Mar 05 2019 | VRAY | ViewRay, Inc. | Matin Shahriar | Chief Operating Off ... | Grant | A | 0.00 | 90,024 | 0 | 692,524 | 602.5 K to 692.5 K (+14.94 %) |
Mar 05 2019 | VRAY | ViewRay, Inc. | Drake Scott William | President & CEO | Option Exercise | A | 8.47 | 314,044 | 2,659,953 | 314,044 | |
Mar 05 2019 | VRAY | ViewRay, Inc. | Drake Scott William | President & CEO | Grant | A | 0.00 | 180,047 | 0 | 1,395,047 | 1.2 M to 1.4 M (+14.82 %) |
Mar 05 2019 | VRAY | ViewRay, Inc. | Dempsey James F. | Chief Scientific Of ... | Option Exercise | A | 8.47 | 66,928 | 566,880 | 66,928 | |
Mar 05 2019 | VRAY | ViewRay, Inc. | Dempsey James F. | Chief Scientific Of ... | Grant | A | 0.00 | 38,371 | 0 | 220,973 | 182.6 K to 221 K (+21.01 %) |
Mar 05 2019 | VRAY | ViewRay, Inc. | BANSAL AJAY | Chief Financial Off ... | Option Exercise | A | 8.47 | 36,038 | 305,242 | 36,038 | |
Mar 05 2019 | VRAY | ViewRay, Inc. | BANSAL AJAY | Chief Financial Off ... | Grant | A | 0.00 | 20,661 | 0 | 90,765 | 70.1 K to 90.8 K (+29.47 %) |
Mar 05 2019 | VRAY | ViewRay, Inc. | Alecxih James | Chief Commercial Of ... | Option Exercise | A | 8.47 | 66,928 | 566,880 | 66,928 | |
Mar 05 2019 | VRAY | ViewRay, Inc. | Alecxih James | Chief Commercial Of ... | Grant | A | 0.00 | 38,371 | 0 | 38,371 | 0 to 38.4 K |
Mar 05 2019 | VRAY | ViewRay, Inc. | Matin Shahriar | Chief Operating Off ... | Option Exercise | A | 8.47 | 157,022 | 1,329,976 | 157,022 | |
Mar 05 2019 | VRAY | ViewRay, Inc. | Matin Shahriar | Chief Operating Off ... | Grant | A | 0.00 | 90,024 | 0 | 692,524 | 602.5 K to 692.5 K (+14.94 %) |
Mar 05 2019 | VRAY | ViewRay, Inc. | Drake Scott William | President & CEO | Option Exercise | A | 8.47 | 314,044 | 2,659,953 | 314,044 | |
Mar 05 2019 | VRAY | ViewRay, Inc. | Drake Scott William | President & CEO | Grant | A | 0.00 | 180,047 | 0 | 1,395,047 | 1.2 M to 1.4 M (+14.82 %) |
Mar 05 2019 | VRAY | ViewRay, Inc. | Dempsey James F. | Chief Scientific Of ... | Option Exercise | A | 8.47 | 66,928 | 566,880 | 66,928 | |
Mar 05 2019 | VRAY | ViewRay, Inc. | Dempsey James F. | Chief Scientific Of ... | Grant | A | 0.00 | 38,371 | 0 | 220,973 | 182.6 K to 221 K (+21.01 %) |
Mar 05 2019 | VRAY | ViewRay, Inc. | BANSAL AJAY | Chief Financial Off ... | Option Exercise | A | 8.47 | 36,038 | 305,242 | 36,038 | |
Mar 05 2019 | VRAY | ViewRay, Inc. | BANSAL AJAY | Chief Financial Off ... | Grant | A | 0.00 | 20,661 | 0 | 90,765 | 70.1 K to 90.8 K (+29.47 %) |
Mar 05 2019 | VRAY | ViewRay, Inc. | Alecxih James | Chief Commercial Of ... | Option Exercise | A | 8.47 | 66,928 | 566,880 | 66,928 | |
Mar 05 2019 | VRAY | ViewRay, Inc. | Alecxih James | Chief Commercial Of ... | Grant | A | 0.00 | 38,371 | 0 | 38,371 | 0 to 38.4 K |
Jan 04 2019 | VRAY | ViewRay, Inc. | Moore Daniel Jeffrey | Director | Grant | A | 6.16 | 14,610 | 89,998 | 33,278 | 18.7 K to 33.3 K (+78.26 %) |
Jan 03 2019 | VRAY | ViewRay, Inc. | Moore Daniel Jeffrey | Director | Grant | A | 0.00 | 18,668 | 0 | 18,668 | 0 to 18.7 K |
Jan 03 2019 | VRAY | ViewRay, Inc. | ROBERTS BRIAN K | Director | Grant | A | 0.00 | 18,668 | 0 | 46,543 | 27.9 K to 46.5 K (+66.97 %) |
Jan 03 2019 | VRAY | ViewRay, Inc. | Puri Aditya | Director | Grant | A | 0.00 | 18,668 | 0 | 61,553 | 42.9 K to 61.6 K (+43.53 %) |
Jan 03 2019 | VRAY | ViewRay, Inc. | Puri Aditya | Director | Grant | A | 6.16 | 10,064 | 61,994 | 42,885 | 32.8 K to 42.9 K (+30.66 %) |
Jan 03 2019 | VRAY | ViewRay, Inc. | MCKINNELL HENRY A | Director | Grant | A | 0.00 | 18,668 | 0 | 689,046 | 670.4 K to 689 K (+2.78 %) |
Jan 03 2019 | VRAY | ViewRay, Inc. | MCKINNELL HENRY A | Director | Grant | A | 6.16 | 8,928 | 54,996 | 670,378 | 661.5 K to 670.4 K (+1.35 %) |
Jan 03 2019 | VRAY | ViewRay, Inc. | Castelein Caley | Director | Grant | A | 0.00 | 18,668 | 0 | 706,630 | 688 K to 706.6 K (+2.71 %) |
Jan 03 2019 | VRAY | ViewRay, Inc. | Castelein Caley | Director | Grant | A | 6.16 | 10,064 | 61,994 | 687,962 | 677.9 K to 688 K (+1.48 %) |
Jan 03 2019 | VRAY | ViewRay, Inc. | Wang Theodore T | Director | Grant | A | 0.00 | 18,668 | 0 | 34,117 | 15.4 K to 34.1 K (+120.84 %) |
Jan 03 2019 | VRAY | ViewRay, Inc. | Wang Theodore T | Director | Grant | A | 6.16 | 7,305 | 44,999 | 15,449 | 8.1 K to 15.4 K (+89.70 %) |
Jan 03 2019 | VRAY | ViewRay, Inc. | Huennekens R Scott | Director | Grant | A | 0.00 | 18,668 | 0 | 34,211 | 15.5 K to 34.2 K (+120.11 %) |
Jan 03 2019 | VRAY | ViewRay, Inc. | Huennekens R Scott | Director | Grant | A | 6.16 | 9,740 | 59,998 | 15,543 | 5.8 K to 15.5 K (+167.84 %) |
Jan 03 2019 | VRAY | ViewRay, Inc. | GROSSMAN D KEITH | Director | Grant | A | 0.00 | 18,668 | 0 | 27,596 | 8.9 K to 27.6 K (+209.09 %) |
Jan 03 2019 | VRAY | ViewRay, Inc. | GROSSMAN D KEITH | Director | Grant | A | 6.16 | 8,928 | 54,996 | 8,928 | 0 to 8.9 K |
Dec 27 2018 | VRAY | ViewRay, Inc. | ROBERTS BRIAN K | Director | Option Exercise | A | 5.21 | 19,116 | 99,594 | 19,116 | |
Dec 26 2018 | VRAY | ViewRay, Inc. | Wang Theodore T | Director | Option Exercise | A | 5.21 | 19,116 | 99,594 | 19,116 | |
Dec 26 2018 | VRAY | ViewRay, Inc. | Wang Theodore T | Director | Option Exercise | A | 5.21 | 19,116 | 99,594 | 19,116 | |
Dec 26 2018 | VRAY | ViewRay, Inc. | MCKINNELL HENRY A | Director | Option Exercise | A | 5.21 | 19,116 | 99,594 | 19,116 | |
Dec 26 2018 | VRAY | ViewRay, Inc. | Huennekens R Scott | Director | Option Exercise | A | 5.21 | 32,547 | 169,570 | 32,547 | |
Dec 26 2018 | VRAY | ViewRay, Inc. | MCKINNELL HENRY A | Director | Option Exercise | A | 5.21 | 19,116 | 99,594 | 19,116 | |
Dec 26 2018 | VRAY | ViewRay, Inc. | Puri Aditya | Director | Grant | A | 8.18 | 2,748 | 22,479 | 32,821 | 30.1 K to 32.8 K (+9.14 %) |
Dec 26 2018 | VRAY | ViewRay, Inc. | Huennekens R Scott | Director | Option Exercise | A | 5.21 | 32,547 | 169,570 | 32,547 | |
Dec 26 2018 | VRAY | ViewRay, Inc. | GROSSMAN D KEITH | Director | Option Exercise | A | 5.21 | 15,685 | 81,719 | 15,685 | |
Dec 26 2018 | VRAY | ViewRay, Inc. | Puri Aditya | Director | Grant | A | 8.18 | 2,748 | 22,479 | 32,821 | 30.1 K to 32.8 K (+9.14 %) |
Dec 26 2018 | VRAY | ViewRay, Inc. | Castelein Caley | Director | Option Exercise | A | 5.21 | 19,116 | 99,594 | 19,116 | |
Dec 26 2018 | VRAY | ViewRay, Inc. | GROSSMAN D KEITH | Director | Option Exercise | A | 5.21 | 15,685 | 81,719 | 15,685 | |
Dec 26 2018 | VRAY | ViewRay, Inc. | Moore Daniel Jeffrey | Director | Option Exercise | A | 5.21 | 32,547 | 169,570 | 32,547 | |
Dec 26 2018 | VRAY | ViewRay, Inc. | Castelein Caley | Director | Option Exercise | A | 5.21 | 19,116 | 99,594 | 19,116 | |
Dec 26 2018 | VRAY | ViewRay, Inc. | Moore Daniel Jeffrey | Director | Option Exercise | A | 5.21 | 32,547 | 169,570 | 32,547 | |
Nov 13 2018 | VRAY | ViewRay, Inc. | Drake Scott William | President & CEO | Buy | P | 6.47 | 60,000 | 388,200 | 1,215,000 | 1.2 M to 1.2 M (+5.19 %) |
Nov 13 2018 | VRAY | ViewRay, Inc. | Matin Shahriar | Chief Operating Off ... | Buy | P | 6.47 | 25,000 | 161,750 | 602,500 | 577.5 K to 602.5 K (+4.33 %) |
Oct 16 2018 | VRAY | ViewRay, Inc. | Alecxih James | Chief Commercial Of ... | Option Exercise | A | 9.09 | 275,000 | 2,499,750 | 275,000 | |
Aug 31 2018 | VRAY | ViewRay, Inc. | Fosun International Ltd | 10% Owner | Buy | C | 8.31 | 3,000,581 | 24,934,828 | 3,000,581 | 0 to 3 M |
Aug 31 2018 | VRAY | ViewRay, Inc. | Fosun International Ltd | 10% Owner | Buy | P | 9.25 | 2,702,702 | 24,999,994 | 2,813,834 | 111.1 K to 2.8 M (+2,431.97 %) |
Aug 31 2018 | VRAY | ViewRay, Inc. | Strong Influence Ltd | 10% Owner | Buy | C | 8.31 | 3,000,581 | 24,934,828 | 3,000,581 | 0 to 3 M |
Aug 24 2018 | VRAY | ViewRay, Inc. | Castelein Caley | Director | Option Exercise | A | 3.17 | 11,092 | 35,162 | 11,092 | |
Aug 24 2018 | VRAY | ViewRay, Inc. | Castelein Caley | Director | Option Exercise | A | 2.95 | 28,636 | 84,476 | 28,636 | |
Aug 20 2018 | VRAY | ViewRay, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 9.98 | 1,466 | 14,631 | 69,617 | 71.1 K to 69.6 K (-2.06 %) |
Aug 20 2018 | VRAY | ViewRay, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 9.98 | 153,921 | 1,536,132 | 7,310,457 | 7.5 M to 7.3 M (-2.06 %) |
Aug 20 2018 | VRAY | ViewRay, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 9.94 | 3,455 | 34,343 | 71,083 | 74.5 K to 71.1 K (-4.64 %) |
Aug 20 2018 | VRAY | ViewRay, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 9.94 | 362,765 | 3,605,884 | 7,464,378 | 7.8 M to 7.5 M (-4.63 %) |
Aug 20 2018 | VRAY | ViewRay, Inc. | Castelein Caley | Director | Grant | A | 9.98 | 510,929 | 5,099,071 | 677,898 | 167 K to 677.9 K (+306.00 %) |
Aug 15 2018 | VRAY | ViewRay, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 9.93 | 736 | 7,308 | 74,538 | 75.3 K to 74.5 K (-0.98 %) |
Aug 15 2018 | VRAY | ViewRay, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 9.93 | 77,314 | 767,728 | 7,827,143 | 7.9 M to 7.8 M (-0.98 %) |
Aug 15 2018 | VRAY | ViewRay, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 9.94 | 198 | 1,968 | 75,274 | 75.5 K to 75.3 K (-0.26 %) |
Aug 15 2018 | VRAY | ViewRay, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 9.94 | 20,777 | 206,523 | 7,904,457 | 7.9 M to 7.9 M (-0.26 %) |